News

Amylin Pharma has posted a net loss, excluding a restructuring charge of $3.4m. Non-GAAP operating loss was $7.4m, a 67% improvement compared to $22.4m for the same period

The agreement funds research at the Gladstone Center for Translational Research led by Gladstone investigator Katerina Akassoglou, PhD and establishes the new Lundbeck Center for Neurovascular and Immuno-imaging

John O’Keefe, CEO of ITelagen, said: “Medficiency has strong established relationships with providers throughout the Mid-Atlantic and Northeast corridor and is a trusted source for their physician clients.

Under a manufacturing agreement signed between Daiichi Sankyo and Sanofi-Aventis in 1993, Sanofi-Aventis has launched Levofloxacin in more than 90 countries as Tavanic. Daiichi Sankyo and Sanofi-Aventis have

ASG-5ME Phase I study, expected to recruit about 50 patients at multiple centers in the US, is a single-agent, open-label, dose-escalation study that will assess the safety and

The chemical pharmaceutical factory with latest technologies is said to have good manufacturing practice (GMP), good storage practice (GSP) and good laboratory practice (GLP). VCP is set to

The relationship will allow clients access to both organizations’ core strengths and geographical expertise. The service expansion will be accomplished through mutual referrals, coordinated sales, marketing, and presentation

Roche said that the product is available in Europe as well as in all countries recognising the CE mark in the Latin America and Asia-Pacific regions. According to

Eli Lilly said that the acquisition, initiated on July 2, 2010, has received the approval of Alnara stockholders and clearance under the Hart-Scott-Rodino Antitrust Improvements Act. As per